Thiogenesis Therapeutics
Thiogenesis Therapeutics is a clinical-stage biopharmaceutical company developing new chemical entities (‘NCE’) that are prodrugs that act as precursors to thiol-active compounds.
Thiogenesis Therapeutics is a clinical-stage biopharmaceutical company developing new chemical entities (‘NCE’) that are prodrugs that act as precursors to thiol-active compounds.